Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer

Ai D, Guan Y, Liu XJ, Zhang CF, Wang P, Liang HL, Guo QS

OncoTargets and Therapy 2016, 9:5693-5698

Published Date: 16 September 2016